NUCRYST Pharmaceuticals Corp. (USA) (NASDAQ:NCST)
CAPS Rating:
The Company develops, manufactures and commercializes innovative medical products that fight infection and inflammation.
The Company develops, manufactures and commercializes innovative medical products that fight infection and inflammation.